Key result
Novel chromosome 15q22 locus linked to ~31% higher early-onset AF risk.
Why the study?
Little is known about population-specific genetic causes of AF and the molecular background of early-onset AF.
Meta-Analysis (n=230,147)
Yes
A nation-wide Norwegian GWAS meta-analysis identified a novel genetic locus on chromosome 15q22 associated with early-onset atrial fibrillation.
Answers are grounded in this paper and cite their sources.
No immediate change to AF management; extends the genetic architecture of early-onset AF with a novel locus.
Background Atrial fibrillation (AF) is a common cardiac arrhythmia affecting more than 40 million individuals worldwide. More than 100 genetic loci have been associated with AF in genome-wide association studies (GWAS) based on pooled, heterogeneous populations. However, less is known about population-specific genetic causes of AF and the molecular background of early-onset AF. In this study we aimed to identify population-specific genetic loci associated with AF in a meta-analysis of GWAS from 4 regional and 1 national population-based health-survey in Norway, and to explore the genetic contribution to early-onset AF. Materials & Methods We included 5 population-based studies, of which 4 were regional and 1 national and included cases with a diagnosis of AF ≥18 years of age and unaffected referents. One of the cohorts included cases with early-onset AF (mean age at onset = 34.9 years; range 19-66 years). DNA was extracted from whole blood from all participants, followed by genotyping, quality control, and imputation. GWAS analyses were performed using the same REGENIE approach in all cohorts. Standardization was performed with MungeSumstats and METAL was used for meta-analysis, which included 7.89 million SNPs. We considered associations with p < 5x10-8 as statistically significant. Results The total number of participants was 230,147 (~30% women), of which 10,821 had an AF diagnosis. We replicated 11 genetic loci (p<5x10-8) from previous GWAS meta-analysis of AF (PITX2, KCNN3, PRRX1, TTN, ERBB4, CAV1, AOPEP, NEURL1, HCN4, ZFHX3, GOSR2). In the MoBa study (n=127,944; 60% women; AF cases=1152), we identified a novel locus for early-onset AF on chromosome 15q22 between C2CD4A and C2CD4B (rs7180689, beta=-0.272, odds ratio=1.31, p=7.16x10-9), previously reported to be associated with type 2 diabetes (beta, -0.0190). The 15q22 locus was also present in the meta-analysis across all studies, but the p-value was just below the genome-wide significance threshold (p=1.23x10-7). Conclusion In this Norwegian nation-wide GWAS meta-analysis, we replicate genetic signals from previous GWAS on AF and identify a novel locus for early-onset AF that previously has been linked to type 2 diabetes. Future studies are needed to replicate and further explore the mechanistic link between the C2CD4A/C2CD4B locus and early-onset AF.
No takes yet. Share an insight, caveat, or question.
Mattingsdal et al. (2025) conducted a meta-analysis in Atrial fibrillation (n=230,147). Genome-wide association study (GWAS) vs. Unaffected referents was evaluated on Genetic loci associated with AF (OR 1.31, p=7.16x10-9). A nation-wide GWAS meta-analysis identified a novel genetic locus for early-onset atrial fibrillation on chromosome 15q22 and replicated 11 previously known AF loci.
Synapse has enriched 10 related papers. Consider them for comparative context: